Hepatocellular carcinoma
Conditions
Interventions
Milan group:liver transplantation
Milan-Hangzhou group:liver transplantation
Beyond Hangzhou group:liver transplantation
Sponsors
Renji Hospital, Shanghai Jiaotong University School of Medicine,Shanghai Institute of Digestive Disease
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. The diagnosis of hepatocellular carcinoma was confirmed in all patients either by computed tomographic scans or by serum alpha-fetoprotein measurement above 400 ng per milliliter and had histological prove after liver transplantation; 2. Histologically proved cirrhosis; 3. Had a history of hepatitis B virus infection, hepatitis B surface antigen positive or serum HBV-DNA positive or histologically proved HBV-relataed cirrhosis; 4. Underwent liver transplantation;
Exclusion criteria
Exclusion criteria: 1. Excluding the hepatocellular carcinoma patients with gross vascular invasion or metastatic disease; 2. Excluding the secondary liver transplantation and combined liver-kidney transplantation(LKT); 3. Excluding other malignant tumors in past history;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5-year recurrence probability;5-year survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| 5-year tumor-free survival probability; | — |
Countries
China
Contacts
Public ContactHai Li
Outcome results
None listed